Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrus R Mehta

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Diabetes Care|November 22, 2018
Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety TrialVenu Menon, A Michael Lincoff, Stephen J Nicholls, et al.
Hypertension (Dallas, Tex. : 1979)|August 3, 2016
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor AlogliptinWilliam B White, Craig A Wilson, George L Bakris, et al.
Lancet (London, England)|March 14, 2015
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P Cannon, William C Cushman, et al.
The New England Journal of Medicine|September 3, 2013
Alogliptin after acute coronary syndrome in patients with type 2 diabetesWilliam B White, Christopher P Cannon, Simon R Heller, et al.
Diabetes Care|June 12, 2016
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialWilliam B White, Stuart Kupfer, Faiez Zannad, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trialSimon R Heller, Richard M Bergenstal, William B White, et al.
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.
The New England Journal of Medicine|February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangiomaChristine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Diabetes Care|November 22, 2018
Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety TrialVenu Menon, A Michael Lincoff, Stephen J Nicholls, et al.
Hypertension (Dallas, Tex. : 1979)|August 3, 2016
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor AlogliptinWilliam B White, Craig A Wilson, George L Bakris, et al.
Lancet (London, England)|March 14, 2015
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P Cannon, William C Cushman, et al.
The New England Journal of Medicine|September 3, 2013
Alogliptin after acute coronary syndrome in patients with type 2 diabetesWilliam B White, Christopher P Cannon, Simon R Heller, et al.
Diabetes Care|June 12, 2016
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialWilliam B White, Stuart Kupfer, Faiez Zannad, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trialSimon R Heller, Richard M Bergenstal, William B White, et al.
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.
The New England Journal of Medicine|February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangiomaChristine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
Pageof 3